Huntleigh Presents Innovative Solutions in Vascular Care, Fetal and Patient Monitoring at MEDICA 2021
|
By HospiMedica International staff writers Posted on 18 Nov 2021 |
|
Huntleigh Healthcare Ltd. (Wales, UK), a member of the Arjo family, presented its innovative solutions in vascular care, fetal and patient monitoring at MEDICA 2021.
MEDICA, the world's largest annual medical technology trade fair, took place from 15-18 November in Düsseldorf, Germany. At the 2021 edition of MEDICA, more than 5,000 exhibitors from 70 countries presented their newest products and ideas. The event also drew more than 120,000 trade visitors from over 170 countries. At MEDICA 2021, Huntleigh presented its Sonicaid Fetal Doppler product portfolio, which encompasses Sonicaid Digital SR2/SR3 2&3 MHz Waterproof Rate Display Dopplers, Sonicaid SRX Digital Doppler, Sonicaid D920/D930 Waterproof Audio Dopplers, and the Sonicaid FD1/FD3 2&3MHz Waterproof Dopplers.
These high sensitivity handheld Digital Dopplers are intended for general purpose screening of the fetal heart at all stages of pregnancy from as early as 8-10 weeks, right through to labor. The attached probes are waterproof (IPX7) for high sensitivity FHR detection in both normal use and in waterbirth monitoring. The high performance transducer enables reliable detection from early gestation right through to delivery, even on obese patients. In addition, Huntleigh displayed its new range of high sensitivity XS probes that have been designed, calibrated and fine-tuned to provide excellent performance over the widest gestational age and BMI range in all clinical settings.
Huntleigh also showcased its Smartsigns patient monitoring range which is capable of delivering a wide range of monitoring options, ranging from hand held or portable devices. Smartsigns patient monitors can be used to monitor the patient’s basic vital signs, through to advanced modular systems used in many low, medium & high acuity settings throughout all areas of healthcare. Huntleigh particularly highlighted its new SC500 Series vital signs monitor which comes with an integrated Early Warning scoring tool (MEWS & NEWS2), and three level alarms, making it ideal for long COVID measurements and observations.
Huntleigh’s extensive experience in vascular assessment was evident at MEDICA 2021, as the company showcased its technologically advanced range of products to improve the efficiency and effectiveness in vascular diagnosis. Huntleigh displayed its Dopplex Ability Automatic Automatic Ankle Brachial Index (ABI) System which has revolutionized the ABI process and provides automatic, easy, fast and accurate measurements with an immediate printout of results from the integral printer or optional DR4 software package. Also on display was the company’s entire vascular assessment Dopplers & kits product portfolio, including Dopplex D900, Dopplex SD2, Dopplex ABI Kit and Dopplex ATP Kit. Huntleigh also displayed its LymphAssist Professional 12 Chamber Intermittent Pneumatic Compression (IPC) System which has been designed to offer clinicians a multi modal treatment option to manage Lymphoedema and associated conditions.
Related Links:
Huntleigh Healthcare Ltd.
Latest COVID-19 News
- Low-Cost System Detects SARS-CoV-2 Virus in Hospital Air Using High-Tech Bubbles
- World's First Inhalable COVID-19 Vaccine Approved in China
- COVID-19 Vaccine Patch Fights SARS-CoV-2 Variants Better than Needles
- Blood Viscosity Testing Can Predict Risk of Death in Hospitalized COVID-19 Patients
- ‘Covid Computer’ Uses AI to Detect COVID-19 from Chest CT Scans
- MRI Lung-Imaging Technique Shows Cause of Long-COVID Symptoms
- Chest CT Scans of COVID-19 Patients Could Help Distinguish Between SARS-CoV-2 Variants
- Specialized MRI Detects Lung Abnormalities in Non-Hospitalized Long COVID Patients
- AI Algorithm Identifies Hospitalized Patients at Highest Risk of Dying From COVID-19
- Sweat Sensor Detects Key Biomarkers That Provide Early Warning of COVID-19 and Flu
- Study Assesses Impact of COVID-19 on Ventilation/Perfusion Scintigraphy
- CT Imaging Study Finds Vaccination Reduces Risk of COVID-19 Associated Pulmonary Embolism
- Third Day in Hospital a ‘Tipping Point’ in Severity of COVID-19 Pneumonia
- Longer Interval Between COVID-19 Vaccines Generates Up to Nine Times as Many Antibodies
- AI Model for Monitoring COVID-19 Predicts Mortality Within First 30 Days of Admission
- AI Predicts COVID Prognosis at Near-Expert Level Based Off CT Scans
Channels
Artificial Intelligence
view channel
AI Analysis of Pericardial Fat Refines Long-Term Heart Disease Risk
Accurately identifying long-term cardiovascular disease risk in asymptomatic adults remains challenging for clinicians. Missed or underestimated risk delays preventive therapy and increases the chance... Read more
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
Critical Care
view channel
Eye Imaging AI Identifies Elevated Cardiovascular Risk
Many adults at risk for atherosclerotic cardiovascular disease are not identified until they undergo formal primary care assessment. Delayed risk recognition can postpone initiation of statins and lifestyle... Read more
Noninvasive Monitoring Device Enables Earlier Intervention in Heart Failure
Hospitalizations for heart failure with preserved ejection fraction (HFpEF) remain common because lung congestion often worsens before symptoms prompt treatment changes. Missed early decompensation... Read more
Surgical Techniques
view channel
Fiber-Form Bone Graft Expands Intraoperative Options for Spinal Fusion
Spinal and orthopedic fusion procedures often require bone graft materials that handle predictably and support bone formation. Surgeons face added complexity in difficult anatomy and challenging fusion environments.... Read more
Ultrasound‑Aided Catheter Treatment Cuts Early Collapse in Pulmonary Embolism
Acute pulmonary embolism can cause rapid hemodynamic deterioration and early death in hospitalized and emergency patients. Systemic thrombolysis can dissolve clots but is limited by a high risk of major... Read more
Patient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Health IT
view channel
Voice-Driven AI System Enables Structured GI Procedure Documentation
Documentation during gastrointestinal (GI) procedures often competes with real-time clinical decision-making and imposes a significant cognitive burden on physicians. Manual data entry and post-procedure... Read more
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Business
view channel
GE HealthCare Leads Major European Initiative to Advance Cardio-Oncology Care
Cardiovascular complications are increasingly recognized among people undergoing or recovering from cancer treatment, driven by pre‑existing disease and the cardiotoxic effects of chemotherapy, radiotherapy,... Read more
